Selskabets formål er at investere i lægemidler og forestå udviklingen af sådanne, enten direkte eller indirekte og enten alene eller i samarbejde med andre samt at fungere som holdingselskab for selskaber indenfor disse områder.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -199 t. | -243 t. | 28 t. | -1.1 mio. | 0 | |
CVR: 37768901
Per Toft Valstorp joined the board
Ulrik Spork joined the board
Jens Morten Fogh joined the board
VALSTORP & COMPANY ApS registered with 20% ownership
registered with 5% ownership
JIMKKS Holding ApS registered with 66% ownership
Beierholm Godkendt Revisionspartnerselskab resigned as auditor
Companies in the same industry and area
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
companydata.dk